Daniel Schrimpf

14.2k total citations
52 papers, 1.7k citations indexed

About

Daniel Schrimpf is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Daniel Schrimpf has authored 52 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Genetics, 24 papers in Molecular Biology and 17 papers in Cancer Research. Recurrent topics in Daniel Schrimpf's work include Glioma Diagnosis and Treatment (31 papers), Chromatin Remodeling and Cancer (9 papers) and Epigenetics and DNA Methylation (7 papers). Daniel Schrimpf is often cited by papers focused on Glioma Diagnosis and Treatment (31 papers), Chromatin Remodeling and Cancer (9 papers) and Epigenetics and DNA Methylation (7 papers). Daniel Schrimpf collaborates with scholars based in Germany, Netherlands and United States. Daniel Schrimpf's co-authors include Andreas von Deimling, David Capper, Stefan M. Pfister, Felix Sahm, David Jones, Andrey Korshunov, David Reuß, Wolfgang Wick, Damian Stichel and Christel Herold‐Mende and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Daniel Schrimpf

49 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Schrimpf Germany 20 1.2k 593 467 399 365 52 1.7k
Felipe Andreiuolo France 24 1.2k 1.0× 721 1.2× 331 0.7× 357 0.9× 617 1.7× 64 1.9k
Andrey Golanov Russia 22 1.0k 0.9× 622 1.0× 332 0.7× 301 0.8× 426 1.2× 162 1.7k
Julie Lejeune France 18 1.1k 0.9× 543 0.9× 394 0.8× 415 1.0× 225 0.6× 33 1.5k
Yasuji Miyakita Japan 22 876 0.7× 348 0.6× 312 0.7× 355 0.9× 304 0.8× 86 1.5k
Arne Christians Germany 12 1.2k 1.0× 664 1.1× 608 1.3× 247 0.6× 260 0.7× 17 1.6k
Dominik Sturm Germany 18 1.1k 1.0× 794 1.3× 348 0.7× 263 0.7× 493 1.4× 55 1.7k
V. Blatt Italy 10 1.3k 1.1× 372 0.6× 291 0.6× 607 1.5× 162 0.4× 17 1.5k
Lynn S. Ashby United States 20 1.1k 0.9× 304 0.5× 196 0.4× 361 0.9× 348 1.0× 46 1.6k
Ralf Ketter Germany 18 1.7k 1.4× 683 1.2× 589 1.3× 743 1.9× 511 1.4× 49 2.5k
Leighann Bailey United States 7 1.3k 1.1× 468 0.8× 457 1.0× 509 1.3× 262 0.7× 13 1.5k

Countries citing papers authored by Daniel Schrimpf

Since Specialization
Citations

This map shows the geographic impact of Daniel Schrimpf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Schrimpf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Schrimpf more than expected).

Fields of papers citing papers by Daniel Schrimpf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Schrimpf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Schrimpf. The network helps show where Daniel Schrimpf may publish in the future.

Co-authorship network of co-authors of Daniel Schrimpf

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Schrimpf. A scholar is included among the top collaborators of Daniel Schrimpf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Schrimpf. Daniel Schrimpf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goeppert, Benjamin, Réka Tóth, Yue Zhang, et al.. (2025). DNA methylation patterns facilitate tracing the origin of neuroendocrine neoplasms. Nature Communications. 16(1). 9477–9477.
2.
Okonechnikov, Konstantin, David R. Ghasemi, Daniel Schrimpf, et al.. (2025). Biglycan-driven risk stratification in ZFTA-RELA fusion supratentorial ependymomas through transcriptome profiling. Acta Neuropathologica Communications. 13(1). 4–4. 1 indexed citations
3.
Hielscher, Thomas, D. Savran, Daniel Schrimpf, et al.. (2024). Meningiomas: Sex-specific differences and prognostic implications of a chromosome X loss. Neuro-Oncology. 27(4). 1019–1028. 1 indexed citations
4.
Keßler, Tobias, Daniel Schrimpf, Leon D. Kaulen, et al.. (2023). Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial. Clinical Cancer Research. 29(19). 3892–3900. 11 indexed citations
5.
Keßler, Tobias, Philipp Eisele, Miriam Ratliff, et al.. (2023). Concurrent gliomas in patients with multiple sclerosis. SHILAP Revista de lepidopterología. 3(1). 186–186. 1 indexed citations
6.
Reuß, David, Daniel Schrimpf, Damian Stichel, et al.. (2023). Reference on copy number variations in pleomorphic xanthoastrocytoma: Implications for diagnostic approach. SHILAP Revista de lepidopterología. 4. 19–19. 2 indexed citations
7.
Korshunov, Andrey, Konstantin Okonechnikov, Daniel Schrimpf, et al.. (2023). Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes. Acta Neuropathologica. 145(6). 829–842. 2 indexed citations
8.
Adeberg, Sebastian, Maximilian Knoll, Christian Koelsche, et al.. (2022). DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma. Acta Neuropathologica. 144(1). 129–142. 7 indexed citations
9.
Lyskjær, Iben, Christopher Davies, Craig Gerrand, et al.. (2022). Osteosarcoma: Novel prognostic biomarkers using circulating and cell-free tumour DNA. European Journal of Cancer. 168. 1–11. 21 indexed citations
10.
Jayavelu, Ashok Kumar, Katharina Filipski, Annekathrin Reinhardt, et al.. (2022). HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma. Neuro-Oncology. 24(12). 2121–2132. 7 indexed citations
11.
Bertero, Luca, Luisella Righi, Christian Koelsche, et al.. (2021). DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic Mimics. Journal of Molecular Diagnostics. 23(7). 834–846. 11 indexed citations
12.
Korshunov, Andrey, Felix Sahm, Konstantin Okonechnikov, et al.. (2019). Desmoplastic/nodular medulloblastomas (DNMB) and medulloblastomas with extensive nodularity (MBEN) disclose similar epigenetic signatures but different transcriptional profiles. Acta Neuropathologica. 137(6). 1003–1015. 4 indexed citations
13.
Röhrich, Manuel, Kristin Huang, Daniel Schrimpf, et al.. (2018). Integrated analysis of dynamic FET PET/CT parameters, histology, and methylation profiling of 44 gliomas. European Journal of Nuclear Medicine and Molecular Imaging. 45(9). 1573–1584. 20 indexed citations
14.
Grund, Kerstin, Dominik Sturm, Christian Sutter, et al.. (2017). Next Generation Sequencing and Pediatric Brain Tumors: Detection of Cancer Predisposition Syndromes in Patients and Their Families. 1(4). 1–1. 36 indexed citations
15.
Varga, Liz, Daniel R. Boué, David Capper, et al.. (2016). SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literature. Child s Nervous System. 32(12). 2439–2446. 13 indexed citations
16.
Heiland, Dieter Henrik, Ori Staszewski, Martin Hirsch, et al.. (2016). Malignant Transformation of a Dysembryoplastic Neuroepithelial Tumor (DNET) Characterized by Genome-Wide Methylation Analysis. Journal of Neuropathology & Experimental Neurology. 75(4). 358–365. 20 indexed citations
17.
Neidert, Marian C., Henning Leske, Jan‐Karl Burkhardt, et al.. (2015). Synchronous pituitary adenoma and pituicytoma. Human Pathology. 47(1). 138–143. 19 indexed citations
18.
19.
Schrimpf, Daniel, et al.. (2010). Web-based open source application for the randomization process in clinical trials: RANDI2. International Journal of Clinical Pharmacology and Therapeutics. 48(7). 465–467. 15 indexed citations
20.
Diel, F., et al.. (1998). Effects of permethrin on human basophils and lymphocytes in vitro. Inflammation Research. 47(0). 11–12. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Felipe Andreiuolo Breakdown of academic impact, for papers by Andrey Golanov Breakdown of academic impact, for papers by Julie Lejeune Breakdown of academic impact, for papers by Yasuji Miyakita Breakdown of academic impact, for papers by Arne Christians Breakdown of academic impact, for papers by Dominik Sturm Breakdown of academic impact, for papers by V. Blatt Breakdown of academic impact, for papers by Lynn S. Ashby Breakdown of academic impact, for papers by Ralf Ketter Breakdown of academic impact, for papers by Leighann Bailey
Rankless by CCL
2026